Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Emily Graffeo, Norah Mulinda, Tim Stenovec

- Moderna (MRNA) shares are up after Wolfe Research upgraded the stock to Peer Perform from Underperform without a price target. Shares surged nearly 180% to $174.38 on Aug. 19, after a late-stage trial showed a treatment combining Moderna and Merck's experimental vaccine, intismeran autogene, and Merck's Keytruda was more effective at preventing skin cancer recurrence than Keytruda alone.

- Dick's Sporting Goods (DKS) shares fell after reporting second-quarter earnings, with earnings per share, revenue, and same-store sales below expectations. The company's Foot Locker division was described as an "albatross" due to structural issues, including over-dependence on a single struggling vendor and aged mall-based real estate.

- Target (TGT) shares fell on Tuesday following criticism over a Halloween costume that sparked an apology from the company. The company removed a Halloween clown costume that critics said evoked blackface imagery, with the Chief Merchandising Officer apologizing to employees and vowing to learn from the mistake. The incident is a setback for Target, which had advanced its stock and improved results under new CEO Michael Fiddelke, and is not the company's first controversy over its products.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Emily Graffeo, Norah Mulinda, Tim Stenovec - Moderna (MRNA) shares are up after Wolfe Research upgraded the stock to Peer Perform from Underperform without a price target. Shares surged nearly 180% to $174.38 on Aug. 19, after a late-stage trial showed a treatment combining Moderna and Merck's experimental vaccine, intismeran autogene, and Merck's Keytruda was more effective at preventing skin cancer recurrence than Keytruda alone. - Dick's Sporting Goods (DKS) shares fell after reporting second-quarter earnings, with earnings per share, revenue, and same-store sales below expectations. The company's Foot Locker division was described as an "albatross" due to structural issues, including over-dependence on a single struggling vendor and aged mall-based real estate. - Target (TGT) shares fell on Tuesday following criticism over a Halloween costume that sparked an apology from the company. The company removed a Halloween clown costume that critics said evoked blackface imagery, with the Chief Merchandising Officer apologizing to employees and vowing to learn from the mistake. The incident is a setback for Target, which had advanced its stock and improved results under new CEO Michael Fiddelke, and is not the company's first controversy over its products.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Closing Bell: Moderna Gains, Dick's Sporting Goods Falls, Target Declines

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ae84b6d6-1da1-4563-81ae-b4b1014e1557/transcript